Macielag M J, Peeters T, Depoortere I
Ohmeda PPD, New Providence, New Jersey, USA.
Int J Pept Protein Res. 1994 Dec;44(6):582-8. doi: 10.1111/j.1399-3011.1994.tb01147.x.
The solid-phase synthesis of two porcine motilin derivatives, specifically biotinylated on the side chain of Lys20, was accomplished by preactivation of the protected amino acids N alpha-(9-fluorenylmethoxycarbonyl)-N epsilon-biotinyl-L-lysine and N alpha-(9-fluorenylmethoxycarbonyl)-N epsilon-[N-(biotinyl)-6-aminohexanoyl]-L-lysine with BOP/HOBt/DIEA (1:1:2.5) followed by coupling to the support-bound peptide substrate. The biotin moiety was stable to TFA cleavage and repetitive cycles of acylation, as evidenced by the high level of purity (> 80%) of the crude peptides. This direct synthetic approach complements existing orthogonal protection strategies for the site-specific biotinylation of peptides. The derivatized peptides were purified by RP-HPLC and characterized by mass spectral and amino acid analysis. In binding studies using a rabbit antral smooth muscle homogenate, both [Leu13, Lys20 (N epsilon-biotinyl)]porcine motilin (3) and [Leu13, Lys20 (N epsilon-[N-(biotinyl)-6-aminohexanoyl])]porcine motilin (4) possessed nearly equal affinities for the motilin receptor (IC50 = 0.89 and 1.2 nM, respectively) as native porcine motilin (1) (IC50 = 0.76 nM). The biotinylated peptides were also highly potent in tissue bath assays employing rabbit duodenal smooth muscle segments. In contrast, commercially available [N alpha-biotinylPhe1]porcine motilin (5) had markedly lower affinity in the binding assay (IC50 = 30 nM). The relative bioactivities of these receptor probes are in accord with previous synthetic studies on motilin which demonstrated the importance of the amino-terminal segment in the high affinity interaction between the peptide and its receptor. Analog 3 retained high affinity for the motilin receptor in the presence of avidin. Therefore, this peptide is expected to be a valuable tool for the isolation and identification of motilin receptors.
通过用BOP/HOBt/DIEA(1:1:2.5)预活化受保护的氨基酸Nα-(9-芴甲氧羰基)-Nε-生物素基-L-赖氨酸和Nα-(9-芴甲氧羰基)-Nε-[N-(生物素基)-6-氨基己酰基]-L-赖氨酸,然后与支持物结合的肽底物偶联,完成了两种猪胃动素衍生物在Lys20侧链上特异性生物素化的固相合成。生物素部分对TFA裂解和重复的酰化循环稳定,粗肽的高纯度(>80%)证明了这一点。这种直接合成方法补充了现有的用于肽位点特异性生物素化的正交保护策略。衍生化的肽通过反相高效液相色谱(RP-HPLC)纯化,并通过质谱和氨基酸分析进行表征。在使用兔胃窦平滑肌匀浆的结合研究中,[Leu13,Lys20(Nε-生物素基)]猪胃动素(3)和[Leu13,Lys20(Nε-[N-(生物素基)-6-氨基己酰基])]猪胃动素(4)对胃动素受体的亲和力与天然猪胃动素(1)几乎相等(IC50分别为0.89和1.2 nM)(IC50 = 0.76 nM)。生物素化的肽在使用兔十二指肠平滑肌段的组织浴试验中也具有高效力。相比之下,市售的[Nα-生物素基苯丙氨酸1]猪胃动素(5)在结合试验中的亲和力明显较低(IC50 = 30 nM)。这些受体探针的相对生物活性与先前关于胃动素的合成研究一致,该研究证明了肽与其受体之间高亲和力相互作用中氨基末端片段的重要性。类似物3在抗生物素蛋白存在下对胃动素受体保持高亲和力。因此,这种肽有望成为分离和鉴定胃动素受体的有价值工具。